RecruitingNot Applicable

China Monogenic Diabetes Registry

China5,000 participantsStarted 2021-02-28

Plain-language summary

This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diabetes diagnosed before 25 years of age; OR diabetes diagnosed before 35 years of age with ≥1 first-degree relative (parent, sibling, or offspring) diagnosed with diabetes before 40 years of age
✓. Body mass index (BMI) at diagnosis 28 kg/m²
✓. Negative glutamic acid decarboxylase antibody (GAD-Ab)

Exclusion criteria

✕. Secondary diabetes
✕. Active malignancy or history of malignant tumor within the past 5 years

What they're measuring

Screened and confirmed monogenic diabetes

Timeframe: 6 months

Trial details

NCT IDNCT07492004

SponsorTianjin Medical University General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-07-31

Contact for this trial

Ming Liu

+86 022-27813550 mingliu@tmu.edu.cn

View on ClinicalTrials.gov More Neonatal Diabetes trials